Old Web
English
Sign In
Acemap
>
authorDetail
>
J. Mueh
J. Mueh
Kaiser Permanente
Follicular phase
Medicine
Lymphoma
Oncology
90Y ibritumomab tiuxetan
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and efficacy of retreating follicular non-Hodgkin’s lymphoma (NHL) with 90Y ibritumomab tiuxetan
2016
Journal of Clinical Oncology
Jatin J. Shah
D. Harrough
Wayne Saville
J. Mueh
John Lister
S. Jasthy
M Gregory
C McKay
R. Krumdieck
Andres Forero
Show All
Source
Cite
Save
Citations (3)
330 SAFETY AND EFFICACY OF RETREATING FOLLICULAR NON-HODGKIN'S LYMPHOMA WITH 90Y IBRITUMOMAB TIUXETAN (ZEVALIN).
2007
Journal of Investigative Medicine
Jatin J. Shah
J. Mueh
John Lister
S. Jasthy
M Gregory
C McKay
R. Krumdieck
Andres Forero
Show All
Source
Cite
Save
Citations (0)
SAFETY AND EFFICACY OF RETREATING FOLLICULAR NON-HODGKINʼS LYMPHOMA WITH 90Y IBRITUMOMAB TIUXETAN (ZEVALIN).: 330
2007
Journal of Investigative Medicine
Jatin J. Shah
J. Mueh
John Lister
S. Jasthy
M Gregory
C McKay
R. Krumdieck
Andres Forero
Show All
Source
Cite
Save
Citations (0)
1